Profile

Mercedes Porosnicu, M.D.Wake Forest Baptist Health

Mercedes Porosnicu, M.D.

Assistant Professor,


Clinical Specialties

Lung Cancer, Head and Neck Cancers

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-713-5440
Department: 336-716-8664

Email: mporosni@wakehealth.edu

Insurance Accepted »

Additional Languages

French, Romanian

Education & Training

  • M.D., Inst Medicine Lasi-Romania , 1987
  • Residency, Suny-Buffalo Affil Hosps, 1998
  • Fellowship, Hematology And Oncology, University of Miami, 2001
  • Fellowship, University of Miami, 2002
  • Fellowship, University of Miami, 2003

Memberships

  • Am Assn Of Cancer Research
  • Am Soc Of Clinical Oncology

NPI Number

  • 1417903584
Mercedes Porosnicu, M.D.Wake Forest Baptist Health

Mercedes Porosnicu, M.D.

Assistant Professor, Hematology & Oncology
Comprehensive Cancer Center
Translational Science Institute

Contact Information

Academic: 336-713-4392 | Department: 336-716-8664

Email: mporosni@wakehealth.edu

Recent Publications

Garg S, Kilburn JM, Randolph DM, Lucas JT, Urbanic JJ, Porosnicu M, Hinson WH, Kearns WT, Greven KM. Re-irradiation for second primary or recurrent cancers of the head and neck: composite dosimetric measures to evaluate dose to the carotid arteries [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S480-S481.

Porosnicu M, Liu J, Lyles D. Susceptibility of head and neck cancer to an attenuated model of the oncolytic vesicular stomatitis virus expressing suicide genes [abstract]. J Clin Oncol. 2010;27(15 Suppl):e14604.

Blackstock A, Petty J, Oaks T, Porosnicu M, Clark H, Lovato J, Miller A. Gefitinig (ZD-1839) with concurrent docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel/gefitinib for patients with stage III NSCLC: a phase I study [abstract]. J Clin Oncol. 2007;25(18 Suppl):Abstr18165.

Blackstock AW, Jensen CA, Petty WJ, Oaks T, Porosnicu M, Clark H, Lovato JF, Miller A. Gefitinib (ZD-1839) with concurrent docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel/gefitinib for patients with stage III NSCLC: a phase I study [abstract]. Int J Radiat Oncol Biol Phys. 2007;69(3 Suppl):S476.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Assistant Professor, Hematology & Oncology

Clinical Specialties

Lung Cancer, Head and Neck Cancers

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.